Home
Live Updates
Achilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Business Highlights : comparemela.com
Achilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Business Highlights
- Patient data from higher dose cNeT as monotherapy and cNeT in combination with checkpoint inhibitor expected in 2H 2022 - - Strong cash position of $266 million supports clinical development and
Related Keywords
Germany ,
Chiron ,
Centre ,
France ,
United Kingdom ,
Spain ,
London ,
City Of ,
Philadelphia ,
Pennsylvania ,
United States ,
John Mullaly ,
Melissa Gardiner ,
Alena Gros ,
Biocapital Europe ,
Markwin Velders ,
Julie Oneill ,
Miraj Ali ,
Mary Jane Elliott ,
Sukaina Virdi ,
Ben Creelan ,
Md Press ,
Biotechnology Index Press ,
Nasdaq ,
Ir External Communications ,
Meetings Press ,
Phd Press ,
Consilium Strategic Communications ,
Tumor Archiving Program ,
Esmoio Congress ,
Chief Executive Officer ,
Artificial Intelligence ,
Scientific Advisory Board ,
Press Release ,
Julieo Neill ,
Material Acquisition Platform ,
Net Combination ,
Gene Therapy Catapult ,
Archiving Program ,
Capital Europe ,
Annual Healthcare Conference ,
Jane Elliott ,
Achilles ,
Herapeutics ,
Reports ,
Fourth ,
Quarter ,
Ear ,
021 ,
Financial ,
Results ,
Ecent ,
Business ,
Highlights ,
comparemela.com © 2020. All Rights Reserved.